5 小結与展望

    由于SARS-CoV-2是一种新型冠状病毒，其生物学特性与MERS、SARS-CoV存在很大差异，其感染过程、病理改变及临床表现与SARS-CoV也有明显差别，本文通过详细比较SARS-CoV-2与SARS-CoV的主要生物学特征异同，归纳总结了参与上述过程的关键靶点，提出了针对这些靶点开发中药源性特异性药物的建议，以期为未来研发防治COVID-19新药提供思路。

    参考文献

    [1] World Health Organizaiton. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV) [EB/OL]. (2020-01-31)[2020-07-10].https：//www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov).

    [2] MALIK Y S ......